Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
Editas Medicine will present at Chardan’s 5th Annual Genetic Medicines Conference on October 4, 2021, at 8:30 a.m. ET. Attendees can access a live webcast through the Investors section of the Editas Medicine website, with an archived replay available for 30 days post-event.
Editas Medicine focuses on delivering transformative genomic medicines utilizing CRISPR technology to treat serious diseases globally. For more details, visit www.editasmedicine.com.
- None.
- None.
CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, will present at Chardan’s 5th Annual Genetic Medicines Conference on Monday, October 4, 2021 at 8:30 a.m. ET.
A live webcast of the presentation will be available on the Investors section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available on the website for approximately 30 days following the presentation.
About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com
Investors
Ron Moldaver
(617) 401-9052
ir@editasmed.com
FAQ
When is Editas Medicine's presentation at the Genetic Medicines Conference?
How can I watch Editas Medicine's presentation at the conference?
Will there be a replay available of Editas Medicine's conference presentation?
What is the focus of Editas Medicine?